|
|
| MRD / Regn No. |
: THBC\23-24\02990 |
Date |
: 17/06/2026 |
| Patient Name |
: Razia Ahmed |
Age & Gender |
: 50 Yrs. / Female |
| Contact No. |
: +971507172073 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
HTN (09/Feb/2021) | DYSLIPIDEMIA (17/Jan/2024) | |
|
Subjective |
: |
HTN- SINCE 3YRS,C/O FROZEN SHOULDER,R/O SHARJAH,DOES NOT TOLERATE ROSUVASTATIN ,TSH BORDERLINE / TG AB - NO MEDS,CAN STOP METOFRMIN ONCE STARTS OZEMPIC
|
|
Objective |
: |
MAY 26,FT3-3.62/FT4-15.98/TSH-7.17,VIT B12-1048.88,VIT D3-31.3,CR-0.78,TC-247/TG-103/HDL-54.86/LDL-172.03,HBA1C-5.5,FBS-92.11,HB-12.1,EGFR-92,JUN 26- HB-11.8,AMYLASE- 101/LIPASE- 61.1,HBA1C- 6.24/FBS- 87.80,AST- 26.2/ALT- 37.4,U ACID-6.48,TC- 179/TG- 84.9/LDL- 112/HDL- 55,TSH- 4.100 |
|
Plan |
: |
IF TAKES BEMEZY - THEN CAN STOP PIVASTA,STARTING OZEMPIC NOW - STOP METFORMIN |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TELMISARTAN 40 MG
TELMA 40 MG |
ORAL |
1-0-0 |
ABF
|
6 MTHS |
|
|
2 |
AMLODIPIN 5MG |
ORAL |
1-0-0 |
ABF
|
6 MTHS |
|
|
3 |
PIVASTA 4MG |
ORAL |
0-0-1 |
ALT DAY
|
6 MTHS |
|
|
4 |
BEMEZY 180 MG |
ORAL |
0-0-1 |
AD
|
6 MTHS |
|
|
5 |
INJ WEGOVY 0.25 MG |
SC |
0.25 MG |
ANYTIME OF DAY
|
4 WEEKS |
|
|
6 |
INJ WEGOVY 0.5 MG |
SC |
0.5 MG |
WEEKLY
|
4 WEEKS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 17/Oct/2026 |
| Tests Suggested For Next Visit |
: HBA1C / TSH > 4 MTHS |
| |
|
| |
|
Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra /
2003/05/2166
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |
|